NCT03737253View on ClinicalTrials.gov

Hormone Evaluation in Artificial Reproductive Technology

NACompletedINTERVENTIONAL
Enrollment

810

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

October 2, 2024

Conditions
Female Infertility
Interventions
DRUG

Follitropin alpha

The objective is to measure the effect of the drug according to gonadotropin receptor genotype.

DRUG

Menotropin

The objective is to measure the effect of the drug according to gonadotropin receptor genotype.

Trial Locations (2)

21428

Reproductive Medicine Center, Malmo

Unknown

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
collaborator

European Commission

OTHER

lead

Lund University

OTHER

NCT03737253 - Hormone Evaluation in Artificial Reproductive Technology | Biotech Hunter | Biotech Hunter